Bruker Corp.'s net earnings jump 19 percent in the second quarter, powered by significant and continuous gains for its scientific instruments segment.

Bruker Corp. (NSDQ:BRKR) saw a 19 percent jump in net earnings during the second quarter.
The Billerica, Mass.-based company reported net earnings of $23 million, or 14 cents per diluted share, on revenue of $301 million during the three months ended June 30. That compares with net earnings of $13 million, or 8 cents per diluted share, on sales of $253 million during the same period last year.
Second-quarter revenue from Bruker's scientific instruments segment was $285 million, up 18 percent from the $241 million recorded in Q2 2009, according to an earnings statement.
"[F]or the second quarter in a row all four operating divisions in our Scientific Instruments segment delivered double-digit organic top-line growth year-over-year," CEO Frank Laukien said in a prepared statement.
Bruker's new chemical analysis division generated some of that revenue, taking in $3.7 million during the last six weeks of the quarter. In May, Bruker closed a $37.5 million acquisition of three former Varian Inc. product lines from Agilent Technologies Inc. (NYSE:A) that it rolled into its chemical analysis division.
Bruker shares were priced at $12.22 in early-afternoon trading, up 7.3 percent.
Warren Watson, a 30-year Medtronic Inc. employee with family connections to founder Earl Bakken, is...
Quidel Corp. wins Food & Drug Administration 510(k) clearance for its chorionic gonadotropin-...
Ann Arbor, Mich.-based HistoSonics Inc. snags former Food & Drug Administration commissioner Dr....
The Food & Drug Administration releases a list of the medical devices it granted 510(k) clearance...
A federal grand jury indicts former Spectranetics CEO John Schulte, two other executives and a...